Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Dalenc

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Revue De L'Infirmiere|May 17, 2008
[Breast cancers]Florence Dalenc
La Revue Du Praticien|March 4, 2014
[Medical treatment of breast cancer: chemotherapy and tailored therapy]Florence Dalenc
La Revue Du Praticien|December 6, 2018
Breast tumoursFlorence Dalenc, Elvire Pons, Henri Roché
Bulletin Du Cancer|February 4, 2020
[Adjuvant endocrine therapy in premenopausal breast cancer: a initial dedicated counseling: can it be useful for better adherence?]Anne Lesur, Florence Dalenc, Marie Beguignot
La Revue Du Praticien|February 6, 2019
Breast cancer diagnostic assessmentFlorence Dalenc, Elvire Pons, Henri Roche
Cancers|August 27, 2021
Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast CancerCamille Franchet, Jean-Sébastien Hoffmann, Florence Dalenc
Cancer Research|August 19, 2018
The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in CancerSandrine Silvente-Poirot, Florence Dalenc, Marc Poirot
Current Medicinal Chemistry|July 17, 2015
Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating PropertiesFlorence Dalenc, Marc Poirot, Sandrine Silvente-Poirot
Bulletin Du Cancer|June 4, 2011
[Medical treatments of endocrine-sensitive Her-2 negative breast cancers: a review]Marc Debled, Florence Dalenc, Louis Mauriac, et al.
Acta Dermato-Venereologica|June 14, 2011
Paronychia and pyogenic granuloma induced by new anticancer mTOR inhibitorsVincent Sibaud, Florence Dalenc, Loic Mourey, et al.
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Revue De L'Infirmiere|May 17, 2008
[Breast cancers]Florence Dalenc
La Revue Du Praticien|March 4, 2014
[Medical treatment of breast cancer: chemotherapy and tailored therapy]Florence Dalenc
La Revue Du Praticien|December 6, 2018
Breast tumoursFlorence Dalenc, Elvire Pons, Henri Roché
Bulletin Du Cancer|February 4, 2020
[Adjuvant endocrine therapy in premenopausal breast cancer: a initial dedicated counseling: can it be useful for better adherence?]Anne Lesur, Florence Dalenc, Marie Beguignot
La Revue Du Praticien|February 6, 2019
Breast cancer diagnostic assessmentFlorence Dalenc, Elvire Pons, Henri Roche
Cancers|August 27, 2021
Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast CancerCamille Franchet, Jean-Sébastien Hoffmann, Florence Dalenc
Cancer Research|August 19, 2018
The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in CancerSandrine Silvente-Poirot, Florence Dalenc, Marc Poirot
Current Medicinal Chemistry|July 17, 2015
Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating PropertiesFlorence Dalenc, Marc Poirot, Sandrine Silvente-Poirot
Bulletin Du Cancer|June 4, 2011
[Medical treatments of endocrine-sensitive Her-2 negative breast cancers: a review]Marc Debled, Florence Dalenc, Louis Mauriac, et al.
Acta Dermato-Venereologica|June 14, 2011
Paronychia and pyogenic granuloma induced by new anticancer mTOR inhibitorsVincent Sibaud, Florence Dalenc, Loic Mourey, et al.
Pageof 18